These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 12091325)
21. Targeting polo-like kinase 1 suppresses essential functions of alloreactive T cells. Berges C; Chatterjee M; Topp MS; Einsele H Immunol Res; 2016 Jun; 64(3):687-98. PubMed ID: 26724940 [TBL] [Abstract][Full Text] [Related]
22. P-glycoprotein targeted photodynamic therapy of chemoresistant tumors using recombinant Fab fragment conjugates. Mao C; Qu P; Miley MJ; Zhao Y; Li Z; Ming X Biomater Sci; 2018 Oct; 6(11):3063-3074. PubMed ID: 30298866 [TBL] [Abstract][Full Text] [Related]
23. Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering. Nonn M; Herr W; Khan S; Todorova M; Link I; Thies J; Distler E; Kaltwasser M; Hoffmann J; Huber C; Hartwig UF Transplantation; 2008 Nov; 86(10):1427-35. PubMed ID: 19034014 [TBL] [Abstract][Full Text] [Related]
24. Consequences of the photodynamic treatment of resting and activated peripheral T lymphocytes. Hunt DW; Jiang H; Granville DJ; Chan AH; Leong S; Levy JG Immunopharmacology; 1999 Jan; 41(1):31-44. PubMed ID: 9950267 [TBL] [Abstract][Full Text] [Related]
25. Cytokine production by subsets of CD4 memory T cells differing in P-glycoprotein expression: effects of aging. Bining N; Miller RA J Gerontol A Biol Sci Med Sci; 1997 May; 52(3):B137-45. PubMed ID: 9158547 [TBL] [Abstract][Full Text] [Related]
26. Rhodamine 123-efflux from hematopoietic subpopulations and leukaemic blast populations marked by PerCP-conjugated monoclonal antibodies. Beck J; Gekeler V; Ringger M; Handgretinger R; Niethammer D Cancer Lett; 1996 Feb; 99(2):197-207. PubMed ID: 8616825 [TBL] [Abstract][Full Text] [Related]
27. P-glycoprotein-targeted photodynamic therapy boosts cancer nanomedicine by priming tumor microenvironment. Mao C; Li F; Zhao Y; Debinski W; Ming X Theranostics; 2018; 8(22):6274-6290. PubMed ID: 30613297 [TBL] [Abstract][Full Text] [Related]
28. "Pruning" of alloreactive CD4+ T cells using 5- (and 6-)carboxyfluorescein diacetate succinimidyl ester prolongs skin allograft survival. Watson D; Zhang GY; Sartor M; Alexander SI J Immunol; 2004 Dec; 173(11):6574-82. PubMed ID: 15557147 [TBL] [Abstract][Full Text] [Related]
29. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy. Johnson BD; Becker EE; LaBelle JL; Truitt RL J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039 [TBL] [Abstract][Full Text] [Related]
30. Selective T-cell depletion for haplotype-mismatched allogeneic stem cell transplantation. Bastien JP; Roy J; Roy DC Semin Oncol; 2012 Dec; 39(6):674-82. PubMed ID: 23206844 [TBL] [Abstract][Full Text] [Related]
31. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution. Gendelman M; Yassai M; Tivol E; Krueger A; Gorski J; Drobyski WR Biol Blood Marrow Transplant; 2003 Dec; 9(12):742-52. PubMed ID: 14677113 [TBL] [Abstract][Full Text] [Related]
32. Selective elimination of alloreactivity from immunotherapeutic T cells by photodynamic cell purging and memory T-cell sorting. Le NT; Chen BJ; Chao NJ Cytotherapy; 2005; 7(2):126-33. PubMed ID: 16040391 [TBL] [Abstract][Full Text] [Related]
33. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro. Muraoka S Eur J Immunol; 1991 Sep; 21(9):2095-103. PubMed ID: 1679712 [TBL] [Abstract][Full Text] [Related]
34. Calcium signal abnormalities in murine T lymphocytes that express the multidrug transporter P-glycoprotein. Witkowski JM; Miller RA Mech Ageing Dev; 1999 Mar; 107(2):165-80. PubMed ID: 10220045 [TBL] [Abstract][Full Text] [Related]
35. Subpopulations of CD4- CD8- murine thymocytes: differences in proliferation rate in vivo and proliferative responses in vitro. Ewing T; Egerton M; Wilson A; Scollay R; Shortman K Eur J Immunol; 1988 Feb; 18(2):261-8. PubMed ID: 2894996 [TBL] [Abstract][Full Text] [Related]
36. Functional assessment and specific depletion of alloreactive human T cells using flow cytometry. Martins SL; St John LS; Champlin RE; Wieder ED; McMannis J; Molldrem JJ; Komanduri KV Blood; 2004 Dec; 104(12):3429-36. PubMed ID: 15284108 [TBL] [Abstract][Full Text] [Related]
37. Efficient depletion of alloreactive donor T lymphocytes based on expression of two activation-induced antigens (CD25 and CD69). Fehse B; Frerk O; Goldmann M; Bulduk M; Zander AR Br J Haematol; 2000 Jun; 109(3):644-51. PubMed ID: 10886218 [TBL] [Abstract][Full Text] [Related]
38. P-glycoprotein (PGP) and lung resistance-related protein (LRP) expression and function in leukaemic blast cells. Michieli M; Damiani D; Ermacora A; Raspadori D; Michelutti A; Grimaz S; Fanin R; Russo D; Lauria F; Masolini P; Baccarani M Br J Haematol; 1997 Feb; 96(2):356-65. PubMed ID: 9029025 [TBL] [Abstract][Full Text] [Related]
39. A comparison of an anti-CD25 immunotoxin, Ontak and anti-CD25 microbeads for their ability to deplete alloreactive T cells in vitro. Vaclavkova P; Cao Y; Wu LK; Michalek J; Vitetta ES Bone Marrow Transplant; 2006 Mar; 37(6):559-67. PubMed ID: 16444279 [TBL] [Abstract][Full Text] [Related]
40. Clinical-scale selective depletion of alloreactive T cells using an anti-CD25 immunotoxin. Michálek J; Collins RH; Vitetta ES Neoplasma; 2003; 50(4):296-9. PubMed ID: 12937844 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]